Martin Stern

3.1k total citations · 1 hit paper
16 papers, 1.6k citations indexed

About

Martin Stern is a scholar working on Immunology and Allergy, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Martin Stern has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology and Allergy, 5 papers in Dermatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Martin Stern's work include Allergic Rhinitis and Sensitization (8 papers), Asthma and respiratory diseases (5 papers) and Respiratory and Cough-Related Research (3 papers). Martin Stern is often cited by papers focused on Allergic Rhinitis and Sensitization (8 papers), Asthma and respiratory diseases (5 papers) and Respiratory and Cough-Related Research (3 papers). Martin Stern collaborates with scholars based in United Kingdom, United States and Germany. Martin Stern's co-authors include Andreas Hector, S. Heyder, Jochen G. Mainz, Lutz Nährlich, Vanya Icheva, Ute Graepler-Mainka, Gloria Herrmann, Erich Gulbins, Joachim Riethmüller and Gerd Döring and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of the Rheumatic Diseases and Allergy.

In The Last Decade

Martin Stern

16 papers receiving 1.5k citations

Hit Papers

Therapy of CF-Patients with Amitriptyline and Placebo - a... 2013 2026 2017 2021 2013 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Stern United Kingdom 10 882 484 342 247 127 16 1.6k
Mitsuko Kondo Japan 25 1.1k 1.2× 349 0.7× 912 2.7× 213 0.9× 72 0.6× 116 1.9k
Mary Baumann United States 18 341 0.4× 392 0.8× 210 0.6× 136 0.6× 145 1.1× 28 1.5k
Joan E. Loader United States 25 403 0.5× 304 0.6× 697 2.0× 240 1.0× 46 0.4× 50 1.6k
B N Hudspith United Kingdom 21 271 0.3× 379 0.8× 593 1.7× 240 1.0× 58 0.5× 48 1.3k
Henry Danahay United Kingdom 24 859 1.0× 642 1.3× 537 1.6× 71 0.3× 52 0.4× 49 1.8k
Sanae Shimura Japan 26 1.1k 1.3× 371 0.8× 867 2.5× 140 0.6× 31 0.2× 104 2.0k
B Lam Hong Kong 23 500 0.6× 280 0.6× 1.0k 3.0× 82 0.3× 74 0.6× 42 1.7k
Cynthia Koziol‐White United States 23 427 0.5× 448 0.9× 615 1.8× 80 0.3× 72 0.6× 66 1.6k
Philip O’Reilly United States 17 603 0.7× 290 0.6× 334 1.0× 51 0.2× 42 0.3× 25 1.4k
R. Robert Schellenberg Canada 29 992 1.1× 345 0.7× 1.4k 4.0× 544 2.2× 62 0.5× 91 2.5k

Countries citing papers authored by Martin Stern

Since Specialization
Citations

This map shows the geographic impact of Martin Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Stern more than expected).

Fields of papers citing papers by Martin Stern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Stern. The network helps show where Martin Stern may publish in the future.

Co-authorship network of co-authors of Martin Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Stern. A scholar is included among the top collaborators of Martin Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Stern. Martin Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Werth, Victoria P., Joan T. Merrill, Richard Furie, et al.. (2021). OP0132 EFFECT OF IBERDOMIDE ON CUTANEOUS MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A 24-WEEK, PLACEBO-CONTROLLED, PHASE 2 STUDY. Annals of the Rheumatic Diseases. 80. 76–77. 7 indexed citations
2.
Schäfer, Claudia, Alix O’Meara, Dimitrios Α. Tsakiris, et al.. (2014). Influence of Selective Serotonin Reuptake Inhibitors on Bleeding Risk in Patients with Severe Thrombocytopenia after Chemotherapy: A Retrospective Study. Acta Haematologica. 133(3). 317–320. 1 indexed citations
3.
Nährlich, Lutz, Jochen G. Mainz, Constantin Adams, et al.. (2013). Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study. Cellular Physiology and Biochemistry. 31(4-5). 505–512. 1203 indexed citations breakdown →
4.
Jiménez-Corona, Aída, et al.. (2007). Risk of Progression to Hypertension in a Low-Income Mexican Population With Prehypertension and Normal Blood Pressure. American Journal of Hypertension. 20(9). 929–936. 24 indexed citations
5.
Koitschev, Assen, et al.. (2005). Standardisierte HNO-Untersuchung bei Patienten mit Mukoviszidose. HNO. 54(5). 361–368. 10 indexed citations
6.
Lorenzo‐Bosquet, Carles, et al.. (2005). Lower hypertension risk in Mexico City than in San Antonio. American Journal of Hypertension. 18(3). 385–391. 9 indexed citations
7.
Luyt, David, et al.. (1999). Open challenge to nuts in children. Allergy. 54(1). 79–80. 6 indexed citations
8.
Howarth, Peter, Martin Stern, Larry D. Roi, Robert F. Reynolds, & Jean Bousquet. (1999). Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis☆☆☆. Journal of Allergy and Clinical Immunology. 104(5). 927–933. 144 indexed citations
9.
Stern, Martin, et al.. (1998). Nasal Budesonide Offers Superior Symptom Relief in Perennial Allergic Rhinitis in Comparison to Nasal Azelastine. Annals of Allergy Asthma & Immunology. 81(4). 354–358. 30 indexed citations
10.
Paul, E., J. Berth‐Jones, Ortonne Jp, & Martin Stern. (1998). Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. Journal of Dermatological Treatment. 9(3). 143–149. 38 indexed citations
11.
Stern, Martin, et al.. (1998). Rapid and Sustained Efficacy of Mizolastine 10 mg Once Daily in Seasonal Allergic Rhinitis. Journal of International Medical Research. 26(6). 292–303. 9 indexed citations
12.
Stern, Martin, Ronald Dahl, Lars Peter Nielsen, Bente Klarlund Pedersen, & Camilla Schrewelius. (1997). A Comparison of Aqueous Suspensions of Budesonide Nasal Spray (128 μg and 256 μg Once Daily) and Fluticasone Propionate Nasal Spray (200 μg Once Daily) in the Treatment of Adult Patients with Seasonal Allergic Rhinitis. American Journal of Rhinology. 11(4). 323–330. 32 indexed citations
13.
Stern, Martin, et al.. (1997). Can an antihistamine delay appearance of hay fever symptoms when given prior to pollen season?. Allergy. 52(4). 440–444. 16 indexed citations
14.
Stern, Martin, et al.. (1990). A comparative study of terfenadine at two dose levels in the management of hayfever. International Journal of Clinical Practice. 44(9). 359–363. 5 indexed citations
15.
Stern, Martin, et al.. (1988). Dose response curve of allergen and histamine in skin prick tests. Allergy. 43(8). 565–572. 6 indexed citations
16.
Sudilovsky, Abraham, et al.. (1987). Comparative Efficacy of Nadolol and Propranolol in the Management of Migraine. Headache The Journal of Head and Face Pain. 27(8). 421–426. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026